Trials / Withdrawn
WithdrawnNCT02846727
Using Fluorescence Angiography to Detect Occult Shock
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if fluorescence angiography can detect occult shock (hypoperfusion).
Detailed description
Hypoperfusion may be multifactorial, due to hemorrhage, shock or other disease processes resulting in either capillary leak into the interstitium or profound vasodilatation. Currently, diagnosis of hypoperfusion depends on indirect markers of perfusion such as lactate, blood pressure, creatinine, urine output, and mental status. These are all late signs of hypoperfusion as they are precursors to impending system failure. In this study, the focus will be on one of the most common causes of hypoperfusion in the surgical population; sepsis and septic shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | skin perfusion image | Upon enrollment following written, informed consent, the patient will receive an injection of 7.5 mg of Indocyanine Green (ICG) intravenously (Dilute 25 mg of Indocyanine Green (ICG) with 10 cc of solvent to achieve a 2.5 mg/cc concentration.) Following injection, Novadaq's LUNA™ fluorescence angiography system will be utilized to map a standard skin perfusion image (SPI) over the upper extremities and anterior chest wall. |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2018-08-01
- Completion
- 2018-09-01
- First posted
- 2016-07-27
- Last updated
- 2018-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02846727. Inclusion in this directory is not an endorsement.